Last updated: October 9, 2024
Sponsor: University of Missouri-Columbia
Overall Status: Completed
Phase
1
Condition
Hemorrhage
Treatment
Tranexamic acid
normal saline
Clinical Study ID
NCT04541303
2025444
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All adult (18 years or older) patients presenting for Mohs micrographic surgery (MMS) for the treatment of melanoma or nonmelanoma skin cancer (NMSC) with a woundthat will be healing by granulation
Exclusion
Exclusion Criteria:
Patients must not be pregnant or breastfeeding.
Patients must not have a known allergic reaction or sensitivity to TXA
Patient must not have an international normalized ratio (INR) out of therapeuticrange if on warfarin.
Study Design
Total Participants: 124
Treatment Group(s): 2
Primary Treatment: Tranexamic acid
Phase: 1
Study Start date:
October 08, 2020
Estimated Completion Date:
December 30, 2021
Study Description
Connect with a study center
University of Missouri-Columbia
Columbia, Missouri 65212
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.